Obeid, Joseph M.
Wages, Nolan A.
Hu, Yinin
Deacon, Donna H.
Slingluff, Craig L. Jr. http://orcid.org/0000-0002-6664-4373
Funding for this research was provided by:
National Cancer Institute (U01 CA178846, T32 CA163177, T32 CA163177, K25 CA181638)
Article History
Received: 15 July 2016
Accepted: 27 September 2016
First Online: 21 October 2016
Compliance with ethical standards
:
: Craig Slingluff Jr., received consulting fees from Immatics, Curetech, Castle Biosciences, and Polynoma, has royalties in University of Virginia Licensing and Ventures Group and was provided PD-1 antibody for use in investigator initiated trial from Merck. All other authors have no conflict of interest to disclose.